Assays to measure nanomolar levels of the renin inhibitor CGP 38 560 in plasma.-Reference-Cited by-同舟云学术

Assays to measure nanomolar levels of the renin inhibitor CGP 38 560 in plasma.

Published:1989-10 Issue:4 Volume:14 Page:379-384
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Cumin F¹,de Gasparo M¹,Wood J M¹,Schnell C¹,Frueh F¹,Graf P¹

Affiliation:

1. Biological Research Department, Ciba-Geigy Limited, Basel, Switzerland.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference14 articles.

1. Effects of a specific and long-acting renin inhibitor in the marmoset.

2. Kleinert HD Martin D Chekal M Young G Rosenberg S Plattner JJ Perun TJ: Cardiovascular actions of the primateselective renin inhibitor A-62198. / Pharmacol Exp Ther 1988;246:975-979

3. A Transition-state Analogue Inhibitor of Human Renin (H.261): Test in vitro and a Comparison with Captopril in the Anaesthetized Baboon

4. Dellaria JF Maki RG Bopp BA Cohen J Kleinert HD Luly JR Merits I Plattner JJ Stein HH: Optimization and in vivo evaluations of a series of small potent and specific renin inhibitors containing a novel Leu-Val replacement. / Med Chem 1987;30:2137-2144

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Modification of the P2‘ Position of 2,7-Dialkyl-Substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: The Discovery of Aliskiren, a Potent Nonpeptide Human Renin Inhibitor Active after Once Daily Dosing in Marmosets;Journal of Medicinal Chemistry;2007-09-08

2. Novel 2,7-Dialkyl-Substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamide Transition State Peptidomimetics Are Potent and Orally Active Inhibitors of Human Renin;Journal of Medicinal Chemistry;2007-09-08

3. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats;Journal of Hypertension;2005-02

4. Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function;Nephrology Dialysis Transplantation;2000-05-01

5. Responses to an Orally Active Renin Inhibitor, Remikiren (Ro 42–5892), After Controlled Salt Depletion in Humans;Journal of Cardiovascular Pharmacology;1995-03